大劑量rmhtnf治療惡性心包積液或惡性胸腔積液的臨床研究

大劑量rmhtnf治療惡性心包積液或惡性胸腔積液的臨床研究

ID:33960561

大?。?.98 MB

頁數(shù):63頁

時間:2019-03-02

大劑量rmhtnf治療惡性心包積液或惡性胸腔積液的臨床研究_第1頁
大劑量rmhtnf治療惡性心包積液或惡性胸腔積液的臨床研究_第2頁
大劑量rmhtnf治療惡性心包積液或惡性胸腔積液的臨床研究_第3頁
大劑量rmhtnf治療惡性心包積液或惡性胸腔積液的臨床研究_第4頁
大劑量rmhtnf治療惡性心包積液或惡性胸腔積液的臨床研究_第5頁
資源描述:

《大劑量rmhtnf治療惡性心包積液或惡性胸腔積液的臨床研究》由會員上傳分享,免費(fèi)在線閱讀,更多相關(guān)內(nèi)容在學(xué)術(shù)論文-天天文庫

1、第二軍醫(yī)大學(xué)碩+學(xué)位論文system,hematologicalsystem,nervoussystem,digestivesystemandrespiratorysystem,especiallyuesdinalloverthebody.Becausetheseadverseevents,theclinicalapplicationofTNF0【hasbeenlimited.From1990s,inordertOimprovethecurativeeffectanddecreasetoxicity,thestudyofmutatedTNFahasbeenextensi

2、velydevolped.RecombinantmutatedhumanTNFaisakindofmutaedTNFahavingimprovedanti—tumoractivityanddecreasedtoxicity,whichisinventedbyTheForthMiilitaryMedcineUnivercity(FMMU).InAugust2003,thefirstmutatedTNFawhichcouldbeuesdinalloverthebodywaslicensed.WefoundthatrmhTNFainducedonlythoracalgiaan

3、dfebrile,seldomreactionofgastrointestinaltract,whenusedintherapyingnonsmall—celllungcancer(NSCLC).IfwegaveantipyreticanalgesicbeforeTNF0twasused,theseadverseeventscouldberelieved.Becausethehalf-lifeofnaturalTNFaisonly10-15min,andithasnospecificaffinitytOtumor,theconcentrationofTNFacannot

4、beelevatedintumor.Inordertoimprovethecurativeeffect,manypeopleinjectnaturalTNFo【Eintotumororcavityandfindthatthecurativeeffectisimprovedandthetoxityisnotincreased.ThemalignantpleuralefusionstherapyingmechanismofrmhTNFaissimilartOnaturalTNFa,includingsupressingtheexpressionofoncogene,dire

5、ctlykillingtumorcells,inducingnecrosisoftumorandfinallyreducingtheproductionofmalignantpleuralefusions.ThehighconcentrationofrmhTNFacaninducestrongerinflammatoryreaction,andleadtothenecrosisandfibrosisoftumor.ItwasalsoprovedthathighconcentrationofrmhTNFacouldinhibittheangiogenesisoftumor

6、.SowepresumedthatrmhTNFacouldbeusedinntracavitaryinicetionandtheconcentrationcouldbeincreasedtoimprovethecurativeeffectmeanwhilethetoxitymightnotbeincreased.Ifthehypothesiscouldbeapproved,theclinicalindicationofrmhTNFacouldbeexpanded,andtherewouldbeanewmethodtocontrolmalignantpleuralefus

7、ions.Toapproveourhypothesis,wecarriedoutthisstudyafterliscencedbyEthicsCommittee.Methods:I.DataofpatientsMalignantpericardialefusions:56patientswithmalignantpericardialefusions,whichwerefinallydiagnosedthroughpathologyorcytology,wererandomlyseperatedintoAgroupandBgroup(28

當(dāng)前文檔最多預(yù)覽五頁,下載文檔查看全文

此文檔下載收益歸作者所有

當(dāng)前文檔最多預(yù)覽五頁,下載文檔查看全文
溫馨提示:
1. 部分包含數(shù)學(xué)公式或PPT動畫的文件,查看預(yù)覽時可能會顯示錯亂或異常,文件下載后無此問題,請放心下載。
2. 本文檔由用戶上傳,版權(quán)歸屬用戶,天天文庫負(fù)責(zé)整理代發(fā)布。如果您對本文檔版權(quán)有爭議請及時聯(lián)系客服。
3. 下載前請仔細(xì)閱讀文檔內(nèi)容,確認(rèn)文檔內(nèi)容符合您的需求后進(jìn)行下載,若出現(xiàn)內(nèi)容與標(biāo)題不符可向本站投訴處理。
4. 下載文檔時可能由于網(wǎng)絡(luò)波動等原因無法下載或下載錯誤,付費(fèi)完成后未能成功下載的用戶請聯(lián)系客服處理。